TGF-β-induced growth inhibition in B-cell lymphoma correlates with Smad1/5 signalling and constitutively active p38 MAPK
Maren K. Bakkebø(Oslo University Hospital), Morten P. Oksvold(Oslo University Hospital)
Cited by 47
Related Papers
Artesunate shows potent anti-tumor activity in B-cell lymphoma
|Journal of Hematology & Oncology|2018|90
The targeting of human and mouse B lymphocytes by dasatinib
|Experimental Hematology|2015|8
Transforming growth factor β superfamily signaling and its role in B-cell lymphoma.
|Duo Research Archive (University of Oslo)|2012|0